Search the Newsreel

Canoe Financial LP Buys 148,999 Shares of Thermo Fisher Scientific Inc. $TMO

Die Thermo-Fisher-Aktie legt nach starken Quartalszahlen zu

Thermo Fisher Scientific Inc. $TMO Shares Purchased by Wealth Enhancement Advisory Services LLC

Smart Fish Wealthlink Sets Board Meeting to Review Interim Results and Dividend

Brown Shipley& Co Ltd Acquires New Shares in Thermo Fisher Scientific Inc. $TMO

Brown Shipley & Co Ltd has acquired 10,509 shares of Thermo Fisher Scientific Inc. (NYSE:TMO) valued at approximately $5.27 million, making it their 11th largest holding. Thermo Fisher Scientific recently reported strong quarterly earnings, exceeding analyst estimates with an EPS of $6.03 and revenue …

Thermo Fisher Scientific and KYAN Technologies Sign MoU to Advance Functional Precision Oncology for Solid Tumours

Thermo Fisher Scientific and KYAN Technologies have signed an MoU to advance functional precision oncology for solid tumours. The collaboration will use patient-derived tumoroid models, functional drug-response screening, and genomic analysis to gather patient-relevant data across various cancers, aiming to improve therapeutic decision-making. They …

Envetec Appoints Patrick S. Jones as Independent Director

Envetec Senior Thermo Fisher Scientific executive brings nearly 30 years of healthcare and commercial leadership to support Envetec's global expansion Patrick S. JonesPatrick S. Jones, President of Thermo Fisher Scientific's Clinical Diagnostics Division and independent director of Envetec Sustainable Technologies BIRDHILL, Ireland, Aug. 14, …

Astorg Cultures a New Diagnostics Company From Thermo Fisher

Astorg Partners has acquired Thermo Fisher Scientific's global microbiology business for $1.075 billion, creating an independent diagnostics company focused on microbial testing. The newly independent entity, which will operate under a new brand and CEO Dirk Bontridder, manufactures consumables and instruments for identifying and …

Fund Update: 3,029,037 THERMO FISHER SCIENTIFIC (TMO) shares added to DODGE & COX portfolio

DODGE & COX has significantly increased its holdings in THERMO FISHER SCIENTIFIC (TMO) by adding 3,029,037 shares, as revealed in a recent SEC 13F filing for the Q2 2026 report period. This move comes amidst varied institutional investor activity, with some firms adding and …

Michael Shafer Sells 25,500 Shares of Thermo Fisher Scientific (NYSE:TMO) Stock

Michael Shafer, EVP of Thermo Fisher Scientific (NYSE:TMO), sold 25,500 shares of the company's stock for $15.3 million, reducing his direct holdings by 54.85%. This sale occurred via a pre-arranged Rule 10b5-1 trading plan. The transaction follows the company's stronger-than-expected quarterly results and a …

Thermo Fisher Scientific Inc. stock falls Thursday, underperforms market

Thermo Fisher Scientific Inc. (TMO) saw its stock price fall by 1.18% on Thursday, closing at $595.89. This performance lagged behind the broader market, as the S&P 500 Index and the Dow Jones Industrial Average both posted gains. This marks the second consecutive day …

Thermo Fisher Scientific (TMO) EVP exercises options, then sells 25,500 shares

Michael D. Shafer, Executive Vice President at Thermo Fisher Scientific (TMO), exercised options for 25,500 shares of common stock at strike prices of $309.63 and $418.32 per share on August 11, 2026. Following the exercise, he sold all 25,500 shares at $600.00 per share, …

Axinn Advises Thermo Fisher Scientific On Completed $1.075 Billion Sale Of Microbiology Business To Astorg

Axinn advised Thermo Fisher Scientific Inc. (NYSE: TMO) on the completed sale of its microbiology business to Astorg, a private equity firm, for approximately $1.075 billion. The microbiology business specializes in antimicrobial susceptibility testing and culture media solutions for clinical, pharmaceutical, and food safety …

Thermo Fisher closes $1.1B sale of microbiology unit to PE firm

Thermo Fisher Scientific has completed the sale of its microbiology unit to European private equity firm Astorg for $1.1 billion. The newly independent company will specialize in microbiology diagnostics, employing approximately 2,400 people across 13 global sites, and will be led by former PerkinElmer …

Die Thermo-Fisher-Aktie reagiert auf starke Q2-Zahlen und angehobene Prognose

Luxembourg: Dirk Bontridder appointed CEO of Astorg’s microbiology diagnostics business following completion of acquisition from Thermo Fisher Scientific

Dirk Bontridder has been appointed CEO of the newly independent microbiology diagnostics platform formed after Astorg completed its acquisition of Thermo Fisher Scientific's global microbiology business. Bontridder brings over 25 years of international leadership experience from the life sciences, diagnostics, and industrial technology sectors, …

Y Intercept Hong Kong Ltd Cuts Stock Position in Thermo Fisher Scientific Inc. $TMO

Y Intercept Hong Kong Ltd significantly reduced its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 84.1% in the second quarter, selling 14,076 shares and retaining 2,669 shares valued at $1.34 million. Despite this, Thermo Fisher Scientific reported strong quarterly earnings, beating analyst estimates …

Fund Update: 22,749 THERMO FISHER SCIENTIFIC (TMO) shares added to Magellan Asset Management Ltd portfolio

Magellan Asset Management Ltd has increased its stake in Thermo Fisher Scientific (TMO) by adding 22,749 shares to its portfolio, as per a recent SEC 13F filing. The article also details significant institutional investor activity, insider trading, government contracts, congressional stock trading, and analyst …

Sheets Smith Wealth Management Raises Holdings in Thermo Fisher Scientific Inc. $TMO

Sheets Smith Wealth Management significantly increased its stake in Thermo Fisher Scientific Inc. by 47.3% in the second quarter, bringing its total holdings to 5,200 shares valued at $2.61 million. This comes as Thermo Fisher Scientific reported strong quarterly earnings, beating analyst estimates with …

Thermo Fisher Sells Microbiology Business for Clinical and Food Safety Testing

Thermo Fisher Scientific (NYSE: TMO) has completed the sale of its microbiology business to Astorg for approximately $1.075 billion. This business specializes in antimicrobial susceptibility testing and culture media solutions for clinical, pharmaceutical, and food safety testing, generating $645 million in revenue in 2025. …

Thermo Fisher Beat Estimates by $300 Million in Q2. Is the Recovery Finally Here?

Thermo Fisher, Michael J. Fox Foundation Expand Parkinson’s Proteomics Resource with 5,500 Samples

Thermo Fisher Scientific and The Michael J. Fox Foundation have expanded the Parkinson’s Precision Medicine Initiative (PPMI) proteomic data resource by analyzing approximately 5,500 research samples using Olink Explore HT technology. This large-scale, open-access dataset is now available in PPMI’s repository to the global …

Thermo Fisher Completes $1.075B Sale of Microbiology Business to Astorg

Thermo Fisher Scientific has finalized the sale of its microbiology business to Astorg for approximately $1.075 billion, which includes cash and a $50 million seller note. This divestiture separates a $645 million-revenue operation from Thermo Fisher's Specialty Diagnostics segment, allowing Astorg to gain control …

Thermo Fisher Scientific Completes Sale of its Microbiology Business to Astorg

WALTHAM, Mass., August 12, 2026--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has completed the sale of its microbiology business to Astorg, a leading pan-European private equity firm, forconsideration of approximately $1.075 billion, consisting of …

Can A New Vitiligo Registry Move The Needle For Thermo Fisher (TMO)?

Thermo Fisher Scientific (NYSE:TMO) mostly sells the instruments and supplies that let other companies do science, not the treatments themselves. So when the company said on July 29 that it had launched the PPD CorEvitas Vitiligo Registry on July 14, to track how patients …

$1000 Invested In Thermo Fisher Scientific 10 Years Ago Would Be Worth This Much Today

Thermo Fisher Scientific (NYSE: TMO) has significantly outperformed the market over the last decade, with an annualized return of 14.61%. An investment of $1000 in TMO stock 10 years ago would now be valued at $3,885.72. This demonstrates the substantial impact of compounded returns …

Thermo Fisher Says India Is One Of Its Fastest-Growing Markets

Thermo Fisher Scientific expects India to remain one of its fastest-growing markets, driven by increasing demands in biopharma, clean energy, and semiconductors, projecting double-digit growth. The company anticipates a 15-20% increase in its Indian customer base over the next five years and plans to …

Thermo Fisher Scientific Collaborates with The Michael J. Fox Foundation to Advance Proteomics-Enabled Parkinson’s Precision Medicine

Thermo Fisher Scientific and The Michael J. Fox Foundation (MJFF) have completed a large-scale proteomic analysis of approximately 5,500 research samples from MJFF's Parkinson’s Precision Medicine Initiative (PPMI) study. This collaboration utilizes Olink technology to expand the PPMI proteomic data resource, making the data …

Kingfisher Metals Exploration Update

HWY 37 and Forrest Kerr Projects | Golden Triangle, British Columbia Three Drill Rigs Active Testing the Hank Area Vancouver, British Columbia--(Newsfile Corp. - August 11, 2026) - Kingfisher Metals Corp. (TSXV: KFR) (FSE: 9700) (OTCQB: KGFMF) ("Kingfisher" or the "Company") provides an update …

Thermo Fisher Scientific (NYSE:TMO) CAO Joseph Holmes Sells 420 Shares

Thermo Fisher Scientific's Chief Accounting Officer, Joseph Holmes, sold 420 shares of company stock for a total of $245,620.20, reducing his direct ownership by 12.4%. Despite the insider sale, Thermo Fisher shares rose 0.8%, and the company exceeded analyst expectations for both quarterly EPS …

Thermo Fisher Scientific Inc. $TMO Shares Sold by Franklin Street Advisors Inc. NC

Franklin Street Advisors Inc. NC reduced its stake in Thermo Fisher Scientific (NYSE:TMO) by 10.4% in the second quarter, selling 9,688 shares but still owning 83,653 shares valued at $41.9 million. Thermo Fisher Scientific reported strong quarterly earnings of $6.03 per share and $11.99 …

How Investors Are Reacting To Thermo Fisher Scientific (TMO) New FDA-Cleared Multiple Myeloma Platform

In late July 2026, Thermo Fisher Scientific used the ADLM conference in Anaheim to highlight new FDA-cleared diagnostic platforms, including the EXENT Solution for multiple myeloma and EliA CTD 13 Screen for systemic autoimmune connective tissue diseases, alongside expanded digital and quality-control offerings for …

Thermo Fisher eyes 15%-20% India customer growth on biopharma research, manufacturing boost

Thermo Fisher Scientific is targeting a 15%-20% increase in its customer base in India over the next five years, driven by the expanding biopharma research and manufacturing sectors. The U.S.-based company, which produces lab and drug development equipment, expects continued double-digit growth in India, …

Kingfisher PLC (KGF.L) Stock Analysis: Navigating a Challenging Market with Strategic Resilience

Thermo Fisher (TMO) vs Danaher (DHR): Which Life Sciences Stock Looks Better Positioned?

Thermo Fisher Scientific Inc. (NYSE:TMO) and Danaher Corporation (NYSE:DHR) are two of the world's largest life sciences tools companies, making them natural competitors for investors looking to capitalize on a recovery in pharmaceutical and biotechnology research spending. Both companies delivered better-than-expected second-quarter results, but …

HF Advisory Group LLC Acquires New Position in Thermo Fisher Scientific Inc. $TMO

HF Advisory Group LLC has acquired a new position in Thermo Fisher Scientific Inc. (NYSE:TMO), purchasing 2,466 shares valued at approximately $1.24 million in the second quarter. Other institutional investors also increased their stakes in the company, bringing total institutional ownership to 89.23%. Analysts …